Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer. | Front Genet | 2023 | 36936424 | PubTator, text mining | PubMed |
| Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. | BMC Bioinformatics | 2023 | 36935487 | PubTator, text mining | PubMed |
| tRNA Modifications and Modifying Enzymes in Disease, the Potential Therapeutic Targets. | Int J Biol Sci | 2023 | 36923941 | PubTator, text mining | PubMed |
| N6-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis. | Int J Biol Sci | 2023 | 36923927 | PubTator, text mining | PubMed |
| Random Forest model reveals the interaction between N6-methyladenosine modifications and RNA-binding proteins. | iScience | 2023 | 36922995 | PubTator, text mining | PubMed |
| Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer. | PeerJ | 2023 | 36919165 | PubTator, text mining | PubMed |
| Attenuation of IFN signaling due to m6A modification of the host epitranscriptome promotes EBV lytic reactivation. | J Biomed Sci | 2023 | 36918845 | PubTator, text mining | PubMed |
| FTO-mediated m6A modification promotes malignant transformation of gastric mucosal epithelial cells in chronic Cag A+ Helicobacter pylori infection. | J Cancer Res Clin Oncol | 2023 | 36918410 | PubTator, text mining | PubMed |
| The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma. | J Bone Oncol | 2023 | 36915895 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells. | Heliyon | 2023 | 36915498 | PubTator, text mining | PubMed |
| Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer. | Front Immunol | 2023 | 36911744 | PubTator, text mining | PubMed |
| Regulation of SUMOylation on RNA metabolism in cancers. | Front Mol Biosci | 2023 | 36911524 | PubTator, text mining | PubMed |
| Editorial: Novel insights in RNA modifications: From basic to translational research. | Front Cell Dev Biol | 2023 | 36910144 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of has_circ_0007905 promotes age-related cataract progression through miR-6749-3p/EIF4EBP1. | PeerJ | 2023 | 36908822 | PubTator, text mining | PubMed |
| The Role of Histone Modification in DNA Replication-Coupled Nucleosome Assembly and Cancer. | Int J Mol Sci | 2023 | 36902370 | PubTator, text mining | PubMed |
| The Role of m6A Modifications in B-Cell Development and B-Cell-Related Diseases. | Int J Mol Sci | 2023 | 36902149 | PubTator, text mining | PubMed |
| RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification. | Biomark Res | 2023 | 36899424 | PubTator, text mining | PubMed |
| Bioinformatics analysis and verification of m6A related genes based on the construction of keloid diagnostic model. | Int Wound J | 2023 | 36896881 | PubTator, text mining | PubMed |
| m6A methylation: Critical roles in aging and neurological diseases. | Front Mol Neurosci | 2023 | 36896007 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine modification in female reproductive biology and pathophysiology. | Cell Commun Signal | 2023 | 36894952 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=61